
AKR1C3-IN-4
CAS No. 1284180-11-5
AKR1C3-IN-4( —— )
Catalog No. M28198 CAS No. 1284180-11-5
AKR1C3-IN-4 is a potent and selective aldo-keto reductase 1C3 (AKR1C3) inhibitor with an IC 50 of 0.56 μM. AKR1C3-IN-4 has the potential for castrate resistant prostate cancer (CRPC) research.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
50MG | 59 | Get Quote |
![]() ![]() |
100MG | Get Quote | Get Quote |
![]() ![]() |
200MG | Get Quote | Get Quote |
![]() ![]() |
500MG | Get Quote | Get Quote |
![]() ![]() |
1G | Get Quote | Get Quote |
![]() ![]() |
Biological Information
-
Product NameAKR1C3-IN-4
-
NoteResearch use only, not for human use.
-
Brief DescriptionAKR1C3-IN-4 is a potent and selective aldo-keto reductase 1C3 (AKR1C3) inhibitor with an IC 50 of 0.56 μM. AKR1C3-IN-4 has the potential for castrate resistant prostate cancer (CRPC) research.
-
DescriptionAKR1C3-IN-4 is a potent and selective aldo-keto reductase 1C3 (AKR1C3) inhibitor with an IC 50 of 0.56 μM. AKR1C3-IN-4 has the potential for castrate resistant prostate cancer (CRPC) research.(In Vitro):AKR1C3-IN-4 has an IC 50 of 15.1 μM for AKR1C2 .
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayMembrane Transporter/Ion Channel
-
TargetNADPH
-
RecptorAntibiotic
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1284180-11-5
-
Formula Weight281.234
-
Molecular FormulaC14H10F3NO2
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 100 mg/mL (355.58 mM)
-
SMILESOC(=O)c1cccc(Nc2ccc(cc2)C(F)(F)F)c1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Hazra S, et al. Tebipenem, a new carbapenem antibiotic, is a slow substrate that inhibits the β-lactamase from Mycobacterium tuberculosis. Biochemistry. 2014 Jun 10;53(22):3671-8.
molnova catalog



related products
-
Acetohexamide
Acetohexamide is a first-generation sulfonylurea medication used to treat diabetes mellitus type 2.
-
AKR1C1-IN-1
AKR1C1-IN-1 is a human 20α-hydroxysteroid dehydrogenase inhibitor (AKR1C1,Ki: 4 nM).AKR1C1-IN-1 inhibits the metabolism of progesterone that in AKR1C1-overexpressed BAECs (IC50:460 nM).
-
gp91 ds-tat
gp91 ds-tat is a NADPH oxidase (NOX2) inhibitor that reduces NOX2 expression.